The integration unifies brand and field strategy, drives executional alignment, and delivers immediate impact measurement
The partnership also sets the stage for broader collaboration on rare disease treatments
This launch is part of the company's strategy to expand its nutraceutical portfolio
Phase one of the expansion will convert an existing hall into an ISO 7-certified cleanroom for GMP-compliant production
PET sheets are widely recognised for their superior clarity, strength, and barrier properties
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
Expanded capabilities that continue to push the boundaries of innovation—advancing drug delivery solutions for patients, customers, and consumers around the world
Agreement further expands Aptar Pharma’s leading position in nasal delivery solutions and addresses significant unmet needs of delivering drugs locally over extended periods
Subscribe To Our Newsletter & Stay Updated
